ARCHIVES

Clinical Trials Approved By NCI

This article is from The Cancer Letter archive.

Vol. 26 No. 9 | September 26, 2003

Download PDF Visit The Full Archive

Related Articles

Roferon A Application Marred By Mission Data, Protocol, Compliance

September 24, 1999

In Congress: Could NCI Make Use Of Increase? Porter Asks; “We Can Handle It Well,” Klausner Replies

April 3, 1998

NIH Reauthorization Still Lingering, Bills ‘Tie Hands’ Of NCI Director

October 18, 1991

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

FDA, Companies Fail To Collect COI Forms, Report Says

January 16, 2009

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001